Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:

Slides:

Advertisements

Similar presentations

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T

Advertisements

Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion Fertility and Sterility

Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H.

Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage

Soyoung Bae, M.D., Joseph Karnitis, M.D. Fertility and Sterility

Evaluation of basal estradiol levels in assisted reproductive technology cycles2 John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.

Michael M. Alper, M.D. Fertility and Sterility

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy Ewa Nowak-Markwitz,

Lauren Groskaufmanis, M.P.H., Saba W. Masho, M.D.

Medical treatment of ectopic pregnancy: a committee opinion

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies Gillian Homan, Susan Brown, R.N., John Moran,

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy Beata E. Seeber, M.D., Mary D.

Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M

Oocyte cryopreservation

How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity Katherine.

Alka Prakash, M. D. , Susan Laird, Ph. D. , Elizabeth Tuckerman, M. Sc

Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort.

Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review Seema Menon, M.D., John.

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T

Robert F. Casper, M.D. Fertility and Sterility

Association of the very early rise of human chorionic gonadotropin with adverse outcomes in singleton pregnancies after in vitro fertilization Christopher.

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

Early serum β-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term.

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model Robin H. Fogle,

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Birth outcomes after spontaneous or assisted conception among infertile Australian women aged 28 to 36 years: a prospective, population-based study Danielle.

Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis

“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss Michelle.

One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above Sigal Klipstein, M.D., Meredith.

First cesarean birth and subsequent fertility

David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

Difference between serum beta-human chorionic gonadotropin levels in pregnancies after in vitro maturation and in vitro fertilization treatments Benny.

Fertility and Sterility

Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D

Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation Allison Styne-Gross, M.D., Karen.

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Website quality assessment: Mistaking apples for oranges

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Luis.

János Urbancsek, M. D. , Ph. D. , Erik E. Hauzman, M. D. , Ana R

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Kayoko Takata, M. D. , Nobuhiko Suganuma, M. D. , Hisae Wada, M. D

Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization David W. Schmidt, M.D.,,

Fertility and Sterility: an evaluation

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Yong Jin Kim, M. D. , Seung-Yup Ku, M. D. , Ph. D. , Byung Chul Jee, M

Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B

Current evaluation of amenorrhea

Fertility and Sterility

The play of chance Fertility and Sterility

Combined use of uterine artery embolization and local methotrexate injection in interstitial ectopic pregnancies with poor prognosis Gemma Tamarit, M.D.,

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

In vitro sildenafil citrate use as a sperm motility stimulant

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

Briana J. Rudick, M. D. , Sue Ann Ingles, Ph. D. , Karine Chung, M. D

Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles

In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation

Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization Sandy Chuan, M.D., Michael Homer,

Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles John L. Frattarelli,

Presentation transcript:

Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization: An analysis of 6021 pregnancies Mousa I. Shamonki, M.D., John L. Frattarelli, M.D., Paul A. Bergh, M.D., Richard T. Scott, M.D. Fertility and Sterility Volume 91, Issue 5, Pages 1760-1764 (May 2009) DOI: 10.1016/j.fertnstert.2008.02.171 Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Logarithmic curves for initial β-hCG and live-birth rates for groups A–D. Group A = age <35 years; group B = age 35–37 years; group C = 38–40 years; group D = 41–42 years. Fertility and Sterility 2009 91, 1760-1764DOI: (10.1016/j.fertnstert.2008.02.171) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Logarithmic curves for initial and percent rise in β-hCG and live-birth rates for all age groups combined. Fertility and Sterility 2009 91, 1760-1764DOI: (10.1016/j.fertnstert.2008.02.171) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions